Page last updated: 2024-08-21

triflusal and Neointima

triflusal has been researched along with Neointima in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Berenguer, A; de la Torre Hernandez, JM; Diaz, JF; Garcia Del Blanco, B; Gomez-Lara, J; Gomez-Menchero, A; Moreno, R; Muñoz-Garcia, E; Otaegui, I; Rondan, J; Rumoroso, JR; Sainz-Laso, F; Subinas, A; Zueco, J	1

Other Studies

1 other study(ies) available for triflusal and Neointima

Article	Year
First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study. Cardiovascular revascularization medicine : including molecular interventions, 2021, Volume: 32 Topics: Coronary Vessels; Drug-Eluting Stents; Humans; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Salicylates; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome	2021

Article

Year

First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study.

Cardiovascular revascularization medicine : including molecular interventions, 2021, Volume: 32

Topics: Coronary Vessels; Drug-Eluting Stents; Humans; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Salicylates; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome

2021